Delivery Order SPE2DB22D3016-SPE2DB25FAZP0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, executed without set-aside designation, represents a competitive award to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The product will be delivered to the same location, supporting the federal government's medical...
- The Defense Logistics Agency awarded a delivery order valued at $7,979.98 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 5 mg/0.5 ml pens. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, issued under a non-competitive, non-set-aside procurement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,904.63 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded pharmaceutical procurement supporting military and federal healthcare needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $4,212.11 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens with a completion date of June 3, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price transaction for the pharmaceutical product to be delivered to the Place of Performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $14,291.18 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on September 23, 2025, with a completion date of September 24, 2025. This is a firm fixed price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens valued at $5,564.41. This delivery order, issued under a firm fixed-price contract with no set-aside designation, is due for completion by July 14, 2025. AmerisourceBergen will fulfill this order from its corporate office in Conshohocken, Pennsylvania, where the company maintains operations as a primary pharmaceutical distributor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,717.60 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 mL pens on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pens on July 22, 2025, with completion expected by July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order fulfilling pharmaceutical supply needs for federal medical procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency (DLA) awarded a $1,632.54 delivery order contract to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Mounjaro 10 mg/0.5 mL pens. This firm fixed-price delivery order, with an ultimate completion date of June 4, 2025, will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,722.19 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen injections on August 27, 2025, with an ultimate completion date of August 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's larger...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FAZP0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $40,073.85 to AmerisourceBergen Drug Corp for the supply of Mounjaro 15 mg/0.5 ml pens on June 16, 2025, with completion scheduled for June 17, 2025. This is a firm fixed price, non-set-aside delivery order for pharmaceutical products to be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a competitively awarded contractor, the company demonstrates the capability to meet federal procurement requirements and routinely fulfills delivery orders ranging from small-value transactions to substantial orders exceeding $45,000, showcasing its versatility in supporting military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.1k | 6/16/25 |